• CRISPRi Targeting Fabp4 in Adipocytes and Liver Disease

  2026-09-07

  This study developed a nonviral, adipose-targeted CRISPR interference system that silences Fabp4 selectively in mature white adipocytes. In obese mice, the approach reduced adiposity and inflammation while improving hepatic steatosis and insulin resistance, illustrating how tissue-specific gene regulation can address systemic metabolic disease.

• Genotyping Kit for Target Alleles: Rapid PCR Workflows

  2026-09-07

  Accelerate allele confirmation across insects, tissues, fishes, and cultured cells with a single-tube workflow that moves from lysis to PCR and electrophoresis with minimal handling. The approach is especially useful for molecular biology genotyping research where throughput, contamination control, and DNA template consistency matter.

• TUNEL Assay for Mechanistic Apoptosis Research

  2026-09-05

  Learn how the TUNEL Apoptosis Detection Kit (DAB) converts DNA fragmentation into interpretable evidence in glioma research. This assay-centered guide connects the Chrysanthemum indicum study to controls, imaging, quantification, and mechanistic validation.

• CLCC1 and Herpesvirus Nuclear Egress

  2026-09-04

  The reference preprint identifies the host factor CLCC1 as essential for the membrane-fusion step that releases herpes simplex virus 1 capsids from the nuclear envelope. Its CRISPR and cell-biological evidence connects herpesvirus nuclear egress with nuclear pore insertion, providing a mechanistic framework for studying host membrane remodeling while highlighting several questions that remain unresolved.

• Nirmatrelvir (PF-07321332): 3CL Protease Research

  2026-09-04

  Nirmatrelvir (PF-07321332) is a SARS-CoV-2 3CL protease inhibitor that blocks viral polyprotein processing. Its defined mechanism, documented physicochemical profile, and compatibility with biochemical and cell-based workflows make it a useful tool for antiviral therapeutics research.

• HotStart Universal 2X FAST Green qPCR Master Mix Guide

  2026-09-03

  Build faster, more reproducible gene expression assays for plant abscission research with a hot-start dye-based workflow and universal ROX normalization. This practical guide translates comparative transcriptomics from Actinidia arguta into target selection, assay design, specificity checks, and troubleshooting decisions.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-03

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody provides fluorescent detection of mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. This guide covers handling, assay setup, controls, and troubleshooting, while emphasizing that the reagent is for research use only and has no supplied clinical or directly matched paper evidence.

• Fasudil (HA-1077) HCl ROCK Inhibitor Workflows

  2026-09-02

  Build reproducible ROCK pathway experiments with Fasudil (HA-1077) HCl across proliferation, migration, and apoptosis assays. This workflow also shows how recent Hippo-pathway research can improve experimental controls without overstating an unvalidated ROCK–Hippo connection.

• 4-Ethylphenyl Sulfate at the Assay Interface

  2026-09-02

  4-Ethylphenyl sulfate is more than a microbiota-derived metabolite: its chemical behavior can influence renal biomarker and gut-brain experiments. This article explains how surface adsorption, matrix design, and targeted measurement should shape translational study decisions.

• CDK9 inhibitor A3294: Protocol and QC Guide

  2026-09-01

  CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation, P-TEFb activity, and HIV-1 propagation in defined research systems. It is appropriate for targeted biochemical and cell-based assays, but not for broad-spectrum CDK inhibition or long-term storage of working solutions.

• ABT-263 (Navitoclax) in Melanoma Senolytic Assays

  2026-09-01

  ABT-263 (Navitoclax) provides a practical way to test whether therapy-induced melanoma senescence remains vulnerable to Bcl-2/Bcl-xL blockade. This workflow combines real-time death imaging, apoptosis validation, and resistance analysis to distinguish true senolytic activity from nonspecific cytotoxicity.

• Ro 3306: Selective CDK1 Inhibitor for G2/M Control

  2026-08-31

  Ro 3306 is an ATP-competitive CDK1 inhibitor that blocks CDK1/cyclin activity and produces cell cycle G2/M phase arrest. Its defined biochemical selectivity and reported effects on BRCA1 and RAD51 support cancer cell synchronization and DNA repair mechanism studies.

• TAI-1: Mechanism and Hec1 Inhibitor Workflow

  2026-08-31

  TAI-1 is a potent Hec1 inhibitor that disrupts the Hec1–Nek2 interaction and promotes mitotic failure in cancer cells. Product data report a GI50 of 13.48 nM in K562 cells, broad anticancer activity, oral efficacy in selected animal models, and preliminary hERG and toxicity findings.

• Tetracycline for Senescence Assay Design

  2026-08-30

  Tetracycline is best understood not only as a broad-spectrum polyketide antibiotic, but also as a variable that can shape experimental context. This article connects its microbiological mechanism with rigorous assay design for LKB1–TERT–telomere research while defining practical boundaries against overinterpretation.

• Genotyping Kit for target alleles: Faster PCR

  2026-08-29

  The Genotyping Kit for target alleles streamlines allele confirmation from insect, fish, tissue, and cell samples by combining single-tube DNA extraction with direct PCR. Its phenol-free workflow is especially useful for barrier-function models, transgenic screens, and experiments that require rapid genotype-to-phenotype decisions.

8505 records 1/567 page Next 12345 下5页 Last page